Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
PRLD · NASDAQ · Pharmaceutical Preparations
$3.23−0.025 (−0.77%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Prelude Therapeutics (PRLD) · oqro.io/stocks/PRLD · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Ra Capital Management, L.P. disclosed a new position in PRLD for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed an increased position in PRLD for Q2 2026SourceInsider trade · Traded Mar 25, 2025 · Filed Mar 27, 2025
CEO purchased ~$467K of PRLD shares in the open marketSourceInsider trade · Traded Mar 21, 2025 · Filed Mar 24, 2025
CEO purchased ~$11K of PRLD shares in the open marketSourceInsider trade · Traded Mar 20, 2025 · Filed Mar 24, 2025
CEO purchased ~$4K of PRLD shares in the open marketSourceInsider trade · Traded Mar 14, 2025 · Filed Mar 18, 2025
CEO purchased ~$23K of PRLD shares in the open marketSourceInsider trade · Traded Mar 17, 2025 · Filed Mar 18, 2025
CEO purchased ~$6.8K of PRLD shares in the open marketSourceInsider trade · Traded Mar 13, 2025 · Filed Mar 14, 2025
CEO purchased ~$36K of PRLD shares in the open marketSourceInsider trade · Traded Mar 12, 2025 · Filed Mar 14, 2025
CEO purchased ~$34K of PRLD shares in the open marketSourceInsider trade · Traded Dec 31, 2024 · Filed Jan 3, 2025
CEO purchased ~$6K of PRLD shares in the open marketSourceInsider trade · Traded Dec 30, 2024 · Filed Jan 2, 2025
CEO purchased ~$12K of PRLD shares in the open marketSourceInsider trade · Traded Dec 23, 2024 · Filed Dec 26, 2024
Officer purchased ~$82K of PRLD shares in the open marketSourceInsider trade · Traded Dec 18, 2024 · Filed Dec 20, 2024
CEO purchased ~$93K of PRLD shares in the open marketSourceInsider trade · Traded Dec 19, 2024 · Filed Dec 20, 2024
CFO purchased ~$23K of PRLD shares in the open marketSourceInsider trade · Traded Dec 19, 2024 · Filed Dec 20, 2024
CEO purchased ~$6.1K of PRLD shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Deerfield Management Company, L.P. disclosed a reduced position in PRLD for Q3 2024Source